You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fusion vaccines

Showing 1 - 25 of 4,011
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)

Active, not recruiting
  • Multiple Myeloma
  • CT-011
  • Dendritic Cell Fusion Vaccine
  • Boston, Massachusetts
  • +2 more
Sep 5, 2022

COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine)

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine
  • Zhuhai, Guangdong, China
    The Fifth Peoples' Hospital of Zhuhai
Feb 15, 2022

COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine 10µg, Recombinant SARS-CoV-2 Fusion Protein

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine 10μg
  • +2 more
  • Zhuhai, Guangdong, China
    Zhuhai Peoples' Hospital Medical Group
Mar 12, 2022

HIV Trial in United States (FP conjugate vaccine (25 mcg), FP conjugate vaccine (200 mcg), Trimer 6931 (100 mcg))

Not yet recruiting
  • HIV
  • FP conjugate vaccine (25 mcg)
  • +5 more
  • Los Angeles, California
  • +6 more
Jul 19, 2022

COVID-19 Pandemic Trial in Malaysia, Pakistan (Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01), Blank Preparation of

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
  • Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
  • Kuching, Sarawak, Malaysia
  • +17 more
Aug 31, 2022

COVID-19 Pandemic Trial in Zhuhai (Recombinant SARS-CoV-2 Fusion Protein Vaccine)

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine
  • Zhuhai, Guangdong, China
    Zhuhai Peoples' Hospital Medical Group
Nov 14, 2021

Covid19 Trial (hAd5-S-Fusion+N-ETSD vaccine)

Withdrawn
  • Covid19
  • hAd5-S-Fusion+N-ETSD vaccine
  • (no location specified)
Dec 14, 2021

Covid19 Trial (hAd5-S-Fusion+N-ETSD vaccine)

Withdrawn
  • Covid19
  • hAd5-S-Fusion+N-ETSD vaccine
  • (no location specified)
Dec 14, 2021

COVID-19 Pandemic Trial in Shaoguan (Recombinant SARS-CoV-2 Beta Variant Fusion Protein Vaccine/Recombinant SARS-CoV-2 Delta

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 Beta Variant Fusion Protein Vaccine/Recombinant SARS-CoV-2 Delta Variant Fusion Protein Vaccine
  • Shaoguan, Guangdong, China
    Shaoguan Hospital of Chinese Medicine
Mar 1, 2022

Lynch Syndrome Trial in Puerto Rico, United States (procedure, drug, other, biological)

Not yet recruiting
  • Lynch Syndrome
  • Biopsy
  • +5 more
  • Phoenix, Arizona
  • +13 more
Sep 16, 2022

Glioblastoma, Glioma, Tumors, Neuroepithelial Trial in Hangzhou (Dendritic Cell/Tumor Fusion Vaccine, Interleukin-12,

Recruiting
  • Glioblastoma
  • +7 more
  • Dendritic Cell/Tumor Fusion Vaccine
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Jun 7, 2020

Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (GM-CSF, Dendritic Cell/Tumor Fusion Vaccine,

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +3 more
Jan 25, 2022

Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention Trial in Worldwide (RSV preF-based Vaccine,

Recruiting
  • Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention
  • RSV preF-based Vaccine
  • Placebo
  • Long Beach, California
  • +27 more
Jan 17, 2023

Acute Myelogenous Leukemia Trial in Atlanta, Boston, Madison (DC/AML Fusion Vaccine, Observation)

Recruiting
  • Acute Myelogenous Leukemia
  • DC/AML Fusion Vaccine
  • Observation
  • Atlanta, Georgia
  • +4 more
Apr 14, 2022

COVID-19 Pandemic Trial in Indonesia, Philippines, Russian Federation (Recombinant SARS-CoV-2 fusion protein vaccine (V-01),

Active, not recruiting
  • COVID-19 Pandemic
  • Recombinant SARS-CoV-2 fusion protein vaccine (V-01)
  • Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
  • Padang, Indonesia
  • +24 more
Aug 31, 2022

Multiple Myeloma Trial in Boston (Nivolumab, DC/myeloma fusions/GM-CSF)

Terminated
Has Results
  • Multiple Myeloma
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 28, 2022

Influenza Vaccination Trial in Singapore (Flublok Quadrivalent vaccine, Fluarix Quadrivalent vaccine, Flucelvax Quadrivalent

Not yet recruiting
  • Influenza Vaccination
  • Flublok Quadrivalent vaccine
  • +2 more
  • Singapore, Singapore
    National Centre for Infectious Diseases (NCID)
Jul 26, 2022

Healthy Trial in United States (Placebo, RSV preF Protein 50 mcg, RSV preF Protein 150 mcg)

Completed
  • Healthy
  • Placebo
  • +8 more
  • Huntsville, Alabama
  • +5 more
Aug 2, 2022

Acute Myelogenous Leukemia Trial in Boston (decitabine, DC/AML fusion cells)

Recruiting
  • Acute Myelogenous Leukemia
  • Boston, Massachusetts
  • +1 more
Nov 15, 2021

Respiratory Syncytial Virus Trial in Worldwide (Ad26.RSV.preF, Placebo, Nimenrix)

Completed
  • Respiratory Syncytial Virus
  • Ad26.RSV.preF
  • +2 more
  • Geelong, Australia
  • +24 more
Nov 23, 2021

Meningococcal Vaccines, Meningococcal Infections, Neisseria Meningitidis Trial in Oxford (4CMenB (Bexsero®) - Novartis Vaccines

Completed
  • Meningococcal Vaccines
  • +3 more
  • 4CMenB (Bexsero®) - Novartis Vaccines and Diagnostics
  • Oxford, Oxfordshire, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine (CCVTM)
Oct 26, 2021

Fibrolamellar Hepatocellular Carcinoma (FLC) Trial in Baltimore (DNAJB1-PRKACA peptide vaccine, Nivolumab, Ipilimumab)

Recruiting
  • Fibrolamellar Hepatocellular Carcinoma (FLC)
  • DNAJB1-PRKACA peptide vaccine
  • +2 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 3, 2022

COVID-19 Trial in United States (drug, biological, other)

Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +21 more
Feb 2, 2023

Vaccine-Preventable Diseases, Herpes Zoster Trial in Zhenjiang (Recombinant Herpes Zoster Vaccine, Recombinant Herpes Zoster

Recruiting
  • Vaccine-Preventable Diseases
  • Herpes Zoster
  • Recombinant Herpes Zoster Vaccine
  • Recombinant Herpes Zoster Vaccine Placebo
  • Zhenjiang, Jiangsu, China
    Jiangsu Province Center for Disease Control and Prevention (Chin
Oct 12, 2023

Nipah Virus Infection Trial run by the NIAID (mRNA -1215)

Recruiting
  • Nipah Virus Infection
  • mRNA -1215
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 30, 2022